Company: BSX
Filing Date: 2025-02-24
Form Type: 424B2
Source: 0001104659-25-016521
Chunk: 2

Company: BOSTON SCIENTIFIC CORP
Filing Date: 2025-02-24
Form: 424B2
Chunk 2
---
 |       99.912% | ​ | ​ | ​ | ​                     | ​ |   0.3375% | ​ | ​ | ​ | ​                                     | ​ |      99.5745% | ​ | ​ |
| 2031 Notes Total | ​ | ​ | ​                          | € |   849,252,000 | ​ | ​ | ​ | ​                     | € | 2,868,750 | ​ | ​ | ​ | ​                                     | € |   846,383,250 | ​ | ​ |
| Per 2034 Note    | ​ | ​ | ​                          | ​ |       99.714% | ​ | ​ | ​ | ​                     | ​ |   0.4250% | ​ | ​ | ​ | ​                                     | ​ |      99.2890% | ​ | ​ |
| 2034 Notes Total | ​ | ​ | ​                          | € |   648,141,000 | ​ | ​ | ​ | ​                     | € | 2,762,500 | ​ | ​ | ​ | ​                                     | € |   645,378,500 | ​ | ​ |
| Total            | ​ | ​ | ​                          | € | 1,497,393,000 | ​ | ​ | ​ | ​                     | € | 5,631,250 | ​ | ​ | ​ | ​                                     | € | 1,491,761,750 | ​ | ​ |

(1) Plus accrued interest, if any, from February 26, 2025. The underwriters expect to deliver the notes to investors through the book-entry system of Clearstream Banking, S.A. (“Clearstream”) and Euroclear Bank SA/NV (“Euroclear”) against payment on or about February 26, 2025. Joint Book-Running Managers

| ​ | Barclays | ​ | ​ | Citigroup | ​ | ​ | Wells Fargo Securities | ​ |

| ​ | BofA Securities | ​ | ​ | J.P. Morgan | ​ | ​ | Société GénéraleCorporate & Investment Banking | ​ |

| ​ | BNP PARIBAS | ​ | ​ | Deutsche Bank | ​ | ​ | Goldman Sachs & Co. LLC | ​ |

| ​ | RBC Capital Markets | ​ | ​ | Scotiabank | ​ | ​ | Standard Chartered Bank | ​ | ​ | TD Securities | ​ |

Co-Manager MUFG The date